Share this page!

Krzysztof Potempa Profile picture
Twitter logo
Nov 16 • 12 tweets • 9 min read
News
1) #MeToo comes to STEM. The @NIH shared new data detailing complaints it has received in recent years, comprising of more than 300 complaints against NIH-funded scientists. Consequently 75 investigators were removed from their grants
@Scatter_Cushion
the-scientist.com/news-opinion/s…
Gisela Rusteholz, Mauro Mediavilla, and Luis Pires published a case study on the Impact of bullying on academic performance. A case study for the Community of Madrid, in IEB working paper 2021/01
ideas.repec.org/p/ieb/wpaper/d…
If witnesses to harassment, members of investigative committees, journal editors, and individuals at every level of the scientific community all leverage their knowledge & power to combat bullying, we can create a safer & more civil #scientific environment
“Bullying often starts off quite subtly, and, if unaddressed, can escalate over time. Having records helps the recipient get a sense as to whether thisis becoming established as a pattern”-@lkeashly
“Academic bullies can leave no trace”-@MoriMahmoudi
#STEM
I went to HR of the department and institution;
I discussed it with a disability adviser;
I discussed it with the international office adviser;
I filed a formal complaint with the dean; I consulted with the ombudsperson.
The outcome of all of this was zero
I complained to the HR representative, who raised the issue to the head of the department, who then spoke to the bully without giving my identity. The bully then emailed the entire group asking the person who had complained to come forward. Nothing changed
science.org/content/articl…
For scholars facing scientific suppression, its key markers include being prevented from pursuing research ideas; having their credibility & practice attacked; & lacking sustained institutional support in their field of enquiry @travisnoakes @ProfTimNoakes
cell.com/heliyon/fullte…
For those of us who work at universities free speech is nothing less than our raison d’être. That is why we must support the academic freedom of people we disagree with; it's the condition of possibility for any form of intellectual disagreement whatsoever
chronicle.com/article/when-a…
Videos of @AcademicParity's “STEM the Bullying” Conference including
@MoriMahmoudi
Sherry Moss
Susanne Täuber
Linda Crockett @BullyingAlberta
Editorial Discussion Panel
@BonSusiBon
Leah Hollis @PatriciaBerkly
@lkeashly
Jennifer Swann @LehighU
#PhdChat #RRI
paritymovement.org/videos-of-stem…
Challenges and burden of the Coronavirus 2019 (COVID-19) pandemic for child and adolescent mental health: a narrative review to highlight clinical and research needs in the acute phase and the long return to normality-Jörg Fegert, Vitiello, Plener, Clemens
capmh.biomedcentral.com/articles/10.11…
People studying and working in academia should also acquaint themselves with narcissism, not for armchair diagnosis and accusations, but rather for potential insights brought from examining different patterns of human behavior @mihalyfy @insidehighered
insidehighered.com/advice/2020/12…
Filling the Space: A Framework for Coordinated Global Actions To Diminish Academic Bullying
@MoriMahmoudi @lkeashly
onlinelibrary.wiley.com/doi/abs/10.100…

• • •

Missing some Tweet in this thread? You can try to force a refresh
　

Keep Current with Krzysztof Potempa

Krzysztof Potempa Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @BRAINCURES

Krzysztof Potempa Profile picture
Nov 16
With increased longevity how do we tackle age-related disease?
How can we engage & empower patients in their healthcare journeys?
How do we increase access to breakthrough therapies for patients with rare diseases?
What's the future of AI in drug discovery
lifescienceintegrates.com/agenda/pharma-… Image
#PharmaIntegrates

An industry is forming around human longevity to treat age-related diseases like dementia and extend our lives. What does this mean for Pharma?

@jamesosh
@TinaWoods
Samantha Benham-Hermetz @AlzResearchUK
@MallucciLab
@RealAaronWeaver
#PharmaIntegrates session that explores advances in asthma treatments, latest research agenda and policies to overcome the burden of this disease with Jorge Bartolome-Areteia Therapeutics
@swoolnough @asthmalunguk
@SalmanRespdoc
@andyroddam @ukfuturehealth
Read 6 tweets
Krzysztof Potempa Profile picture
Nov 15
“When I was shadow foreign secretary-I did hear a number of rumours that this was a pattern of behaviour within the department. I think it’s been something of an open secret within Westminster for the last few years that there is a problem"
MP @lisanandy
mirror.co.uk/news/politics/…
Lord McDonald who worked in the @FCDOGovUK when @DominicRaab was appointed foreign secretary in 2019, told @MattChorley’s show that the systems in government for allowing civil servants to make complaints about ministerial behavior were not fit for purpose
thetimes.co.uk/article/d16b29…
"He claimed zero tolerance for bullying, promised a government of integrity and pledged to urgently appoint an ethics adviser, yet is falling far short on every promise. @RishiSunak is not just failing to stop the rot but letting it fester." @AngelaRayner
news.sky.com/story/dominic-…
Read 6 tweets
Krzysztof Potempa Profile picture
Nov 14
Ahead of Elizabeth Holmes’ sentencing this week, prosecutors ask for 15 years hard time. In an 82-page sentencing memorandum filed last Thursday, @eholmes2003’ team petitioned US District Judge Edward Davila to limit her time in prison to 18 months or less
fiercebiotech.com/medtech/ahead-…
As Elizabeth Holmes @eholmes2003 trial nears an end, here’s a brief recap of the rise and fall of blood testing startup @theranos from its peak as a Silicon Valley darling to its current status as cautionary tale turned punchline
Andrea Park @FierceBiotech
fiercebiotech.com/medtech/elizab…
“I was just totally isolated. I was told that the only people I could talk to about this were my wife, my priest, and my lawyer. And I wasn’t married, I’m not religious, and my lawyers are extremely expensive.”
@theranos biotech whistleblower @TylerShultz_
Read 13 tweets
Krzysztof Potempa Profile picture
Nov 14
While the GRADUATE results are not what we hoped, we are proud to have delivered a high quality and comprehensive Alzheimer’s dataset to the field, and we look forward to sharing our learnings with the community as we continue to search for new treatments-Levi Garraway CMO @Roche
1,965 Alzheimer's disease study participants across 30 countries were randomised 1:1 to receive gantenerumab or placebo by subcutaneous injection every 2 weeks.
Phase 3 GRADUATE I & II studies did not meet their primary endpoint of slowing clinical decline
The primary endpoint for the Phase III gantenerumab study was the change from baseline on the Clinical Dementia Rating-Sum of Boxes-CDR-SB at 116 weeks. The CDR-SB measures cognitive and functional change across six areas. There were 17 secondary endpoints
roche.com/media/releases…
Read 7 tweets
Krzysztof Potempa Profile picture
Nov 14
We’re all familiar with the old saying “sticks and stones may break my bones but words will never hurt me.” @mcflyharry @Konnie_Huq recount their experiences of being bullied in school and how they navigate bullying now that they have children of their own
bbc.co.uk/bitesize/artic…
As a parent it can be difficult to identify bullying as it's happening. Star parents @mcflyharry @Konnie_Huq discuss their own experiences of bullying in school, how to spot the signs of #bullying & ways to approach the subject with your child @bbcbitesize
bbc.co.uk/bitesize/artic…
#AntiBullyingWeek, '#ReachOut', is about encouraging children, teachers and parents to speak up and talk to each other about bullying, in all its forms. This conversation can often be difficult @mcflyharry @Konnie_Huq #ParentsToolkit @marfevans @ABAonline
bbc.co.uk/bitesize/artic…
Read 4 tweets
Krzysztof Potempa Profile picture
Oct 19
🧵When resources are limited, the question of what knowledge is needed and when — the ‘decision gate’ analogy — becomes the principal strategic consideration in determining the priority of activities during early drug development
@NatRevDrugDisc #biotech
nature.com/articles/nrd11…
Evidence showing ligands & receptors to be variable and discerning instigators of signals, and translators of information, respectively, have illustrated the fallacy of assuming that the surrogate host cell is an inert vessel-Terry Kenakin @NatRevDrugDisc
nature.com/articles/nrd11…
Stepping back from the rather safe HTS paradigm to discovery in virtual space which is still not yet fully developed, certainly needs courageous management decisions not only in terms of financial investments, but also in organizational evolution @Aalanine
nature.com/articles/nrd10…
Read 32 tweets

Did Thread Reader help you today?

Support us! We are indie developers!

This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us on Twitter!

Send Email!

:(